Goldman Sachs Asset Management launches two new ETFs on NYSE

Goldman Sachs Asset Management has launched two new exchange-traded funds (ETFs) on the New York Stock Exchange (NYSE). The GCPB ETF is designed to provide new types of core plus bond exposure, while the GINC ETF focuses on balancing income potential with diversification.

Additionally, LifeMine Therapeutics CEO Greg Verdine is highlighting the biopharmaceutical company’s recent $263 million capital raise. The firm is using these funds to accelerate clinical development for its lead program, LIFE-001, which aims to prevent organ transplant rejection.

Market observers are also monitoring the S&P 500 as it attempts to build on recent record closes amid ongoing developments in the Middle East.